Are Russian public sector workers getting coerced into participating in the Phase 3 Sputnik V COVID-19 vaccine trial in that country? If a recent Reuters report is correct, the answer is unfortunately affirmative. Although actual visits to clinical trial sites where...
Sputnik V
Category
Russian Sputnik V Vaccine Claimed to be 95% Effective After 48-Day Second Dose
TrialSite has followed the Russian COVID-19 vaccine called Sputnik V. In a form of what could be perceived as a national competition or even so-called “Vaccine Nationalism” that country supported some highly questionable research tactics including pre-clinical testing...
Russia Claims 92% Efficacy of Sputnik V COVID-19 Vaccine: Timing of the Announcement Interesting
The Russian Direct Investment Fund (RDIF), a sovereign wealth fund behind intimately involved in that nation’s COVID-19 response effort along with the National Research Center for Epidemiology and Microbiology (Gamaleya Institute) recently reported that the Sputnik V...
RDIF Seeking Licensing Deal with Brazilian Pharma to Produce & Distribute Vaccine in Southern State of Parana
The Russian vaccine known as “Sputnik V,” developed by the Gamaleya National Research Institute of Epidemiology and Microbiology, was registered by the Ministry of Health in Russia back on Aug 11. This was viewed as a controversial move by the global biopharmaceutical...
Major Generic Drug Maker in India Embraces Russia’s COVID-19 Vaccine Sputnik V
Dr. Reddy’s Laboratories Ltd. has embraced the Russian COVID-19 vaccine known as Sputnik V after receiving approval by the Drug Controller of India (DCGI) to conduct an adaptive Phase 2/3 clinical trial vaccine in India. A multicenter and randomized controlled study,...
Russia’s Sputnik V Expands to UAE: Phase 3 Clinical Trial Approved
Previously, TrialSite has covered the Russian Direct Investment Fund (RDIF) and their involvement with that country’s COVID-19 therapy and vaccine development programs. Now, the organization’s chief, Kirill Dmitriev, has emerged as an international drug development...
Is Sputnik V Sputtering in Southeast Asia? The Philippines Waits
TrialSite was the “US watchdog” referenced to by Jeremaiah M. Opinano in a recent Aug. 12 article in The Filipino Connection titled “US trials watchdog to PHL: Be ‘cautious’ in trying out ‘Sputnik V’ vaccine.” TrialSite commented that although it certainly wished the...
Russia Aggressively Marketing Sputnik V Around the World with Deepening Discussion in India
Of the at least 36 vaccine candidates tracked by the World Health Organization (WHO) targeting COVID-19, a batch of leading candidates either comes from Germany, The UK, the United States, China, and two from India, including Bharat Biotech International and Cadila...
Sputnik V vs. Sinopharm’s Vaccines? Egypt Purportedly Opting for Sinopharm
Russia has been assertively courting Egypt to embrace the Sputnik V vaccine; after all, Russia’s health ministry had registered the product, meaning it was approved for use. However, Egypt has opted for two vaccines developed by Chinese company Sinopharm according to...
Russian Vaccine Redux: EpiVacCorona “Approval” Soon?
Before the dust has settled from Russia’s rushed deployment of Sputnik V, the vaccine developed by the Gamaleya Institute, Phase 2 trials are now complete for a second COVID-19 vaccine, dubbed EpiVacCorona. In August, Reuters reported that Russia was “preparing” to...
Prominent Indian Investigator: Not Primetime for Sputnik V COVID-19 Vaccine Yet
The COVID-19 pandemic has moved into India in a big way as that country becomes the second most impacted worldwide next to the United States. India now has reported over 4.3 million cases and nearly 74,000 deaths. A few indigenous vaccines are underway and in clinical...
The Lancet: Russian “Sputnik V” Vaccine Safe and Produces Antibodies to COVID-19
On September 4, CNBC reported on a new Lancet study showing both “no serious adverse” effects and an antibody response from Russia’s vaccine. The trials involved 76 healthy volunteers; and the authors say that, “Large, long-term trials including a...
Israel will Meet with Gamaleya Once Sputnik V Goes Through the Rigor of Phase 3 Clinical Trials
The state-owned Russian media TASS claims that at least 20 nations have sought to purchase at least 1 billion doses of the Gamaleya (Sputnik V) COVID-19 vaccine. Yuli Edelstein, Israeli Health Minister, is on the record that his nation would consider the vaccine if it...
Sputnik V Approved & Moves to Phase 3, US Officials Skeptical
As we last covered on August 11, Russia’s Gamaleya/Sputnik V vaccine presents both a chance at solving our global pandemic and a need to scrutinize the evidence for efficacy and safety, along with myriad scientific and ethical questions related to how the...